Memorial Sloan Kettering medical oncologist Louise Connell

Louise Catherine Connell, MB BCh BAO, BMedSc

Medical Oncologist

Clinical Expertise

Colon Cancer; Rectal Cancer; Other Gastrointestinal Cancers; Hepatic Arterial Infusion Chemotherapy for Colorectal Cancer

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Connell accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me

Education

MB BCh BAO BMedSc, University College Cork, Ireland

Residencies

Internal Medicine - Royal College of Physicians of Ireland

Fellowships

Medical Oncology - Royal College of Physicians of Ireland; Advanced Medical Oncology - Memorial Sloan Kettering Cancer Center

Board Certifications

Internal Medicine (Ireland); Medical Oncology (Ireland and Europe)

I am a medical oncologist whose practice is dedicated to caring for people with gastrointestinal cancers. These include colon cancer, rectal cancer, and appendiceal cancer. I also have expertise in treating hepatobiliary cancers. I specialize in systemic chemotherapy, where the treatment circulates throughout the body, and regional chemotherapy, meaning the drug is delivered directly to the liver or abdomen. I see patients at MSK’s Rockefeller Outpatient Pavilion, in Manhattan.

The goal of my research is to develop new, more-personalized therapies for people with colorectal and hepatobiliary cancers. For example, we are working to develop immunotherapy and molecular-based approaches to effectively treat these diseases. I have a particular interest in advancing our understanding of colorectal cancers at the molecular level so that we can learn how and why they grow and spread.

As a medical student unsure of the exact path my career would take, my family was impacted by cancer. The journey that followed influenced me both in terms of my career choices and goals, and also how I care for patients today. My experience being on the other side of the consultation desk helped me to understand and appreciate what patients and their families go through after receiving a cancer diagnosis.

When caring for my patients, I aim to provide the best evidence-based treatments and to surround them with compassion. I place a great deal of emphasis on communication to help reduce their distress and maximize their quality of life.

Awards and Honors

  • Irish Society of Medical Oncology Scholarship Award (2013)
  • Ainsworth Scholarship (2014)
  • American Society of Clinical Oncology (ASCO) Young Investigator Award (2016)

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases. Connell LC, Boucher TM, Chou JF, Capanu M, Maldonado S, Kemeny NE.J Surg Oncol. 2017 Mar;115(4):480-487. doi: 10.1002/jso.24536. Epub 2016 Dec 23.PMID:28008623

Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies. Cercek A, Boucher TM, Gluskin JS, Aguiló A, Chou JF, Connell LC, Capanu M, Reidy-Lagunes D, D’Angelica M, Kemeny NE.J Surg Oncol. 2016 Nov;114(6):655-663. doi: 10.1002/jso.24399. Epub 2016 Aug 26.PMID:27566258

The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment. Connell LC, Mota JM, Braghiroli MI, Hoff PM. Curr Treat Options Oncol. 2017 Apr;18(4):23. doi: 10.1007/s11864-017-0463-3. PMID:28391421

Combined Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma. Connell LC, Harding JJ, Shia J, Abou-Alfa GK.Chin Clin Oncol. 2016 Oct;5(5):66. doi: 10.21037/cco.2016.10.02. PMID: 27829279 

Advanced Hepatocellular Cancer: The Current State of Future Research. Connell LC, Harding JJ,Abou-Alfa GK. Curr Treat Options Oncol. 2016 Aug;17(8):43. doi: 10.1007/s11864-016-0415-3. PMID:27344158

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies.  Naidoo J, Page DB, Li BT, Connell LC, Schindler K, Lacouture ME, Postow MA, Wolchok JD.  Ann Oncol. 2015 Dec;26(12):2375-91. PMID:27072927

Publications on PubMed

Visit PubMed for a full listing of Dr. Connell’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.